StockWatch
·

ABVC BIOPHARMA, INC. Q3 FY25 Results

ABVCQ3 FY25 Results
MetricValue ($ M)Q3 FY24
Revenue0.80105.1%
Total Income0.80105.1%
Expenditure1.96184.1%
PBT-1.29163.3%
Net Profit-1.25220.5%
OPM—
NPM—
EPS-0.0566.7%
View full financials

Informational and educational content only. Not investment advice.